Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Operating Expenses (2016 - 2025)

Surgery Partners' Operating Expenses history spans 12 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Operating Expenses rose 42.18% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $2.9 billion, up 14.28%, while the annual FY2025 figure was $2.9 billion, 5.56% up from the prior year.
  • Operating Expenses for Q4 2025 was $1.0 billion at Surgery Partners, up from $626.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.0 billion in Q4 2025 and bottomed at $306.2 million in Q4 2021.
  • The 5-year median for Operating Expenses is $535.6 million (2022), against an average of $577.4 million.
  • The largest annual shift saw Operating Expenses decreased 25.84% in 2021 before it surged 70.74% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $306.2 million in 2021, then soared by 70.74% to $522.8 million in 2022, then soared by 64.75% to $861.3 million in 2023, then dropped by 14.4% to $737.3 million in 2024, then surged by 42.18% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Operating Expenses are $1.0 billion (Q4 2025), $626.2 million (Q3 2025), and $630.6 million (Q2 2025).